|
|
||||||||
Departments of 1 Anesthesiology and 2 Physiology, Miyazaki Medical College, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan
Leptin, the product of the ob gene, is a satiety factor secreted mainly in adipose tissue and is part of a signaling mechanism regulating the content of body fat. It acts on leptin receptors, most of which are located in the hypothalamus, a region of the brain known to control body homeostasis. The fastest and strongest hypothalamic response to leptin in ob/ob mice occurs in the paraventricular nucleus, which is involved in neuroendocrine and autonomic functions. On the other hand, orexins (orexin-A and -B) or hypocretins (hypocretin-1 and -2) were recently discovered in the hypothalamus, in which a number of neuropeptides are known to stimulate or suppress food intake. These substances are considered important for the regulation of appetite and energy homeostasis. Orexins were initially thought to function in the hypothalamic regulation of feeding behavior, but orexin-containing fibers and their receptors are also distributed in parts of the brain closely associated with the regulation of cardiovascular and autonomic functions. Functional studies have shown that these peptides are involved in cardiovascular and sympathetic regulation. The objective of this article is to summarize evidence on the effects of leptin and orexins on cardiovascular function in vivo and in vitro and to discuss the pathophysiological relevance of these peptides and possible interactions.
mean arterial pressure; heart rate; sympathetic nerve activity; catecholamine; hypothalamic paraventricular nucleus; depolarization; sympathoexcitation
This article has been cited by other articles:
![]() |
T. Tsunematsu, L.-Y. Fu, A. Yamanaka, K. Ichiki, A. Tanoue, T. Sakurai, and A. N. van den Pol Vasopressin Increases Locomotion through a V1a Receptor in Orexin/Hypocretin Neurons: Implications for Water Homeostasis J. Neurosci., January 2, 2008; 28(1): 228 - 238. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-S. Deng, A. Nakamura, W. Zhang, M. Yanagisawa, Y. Fukuda, and T. Kuwaki Contribution of orexin in hypercapnic chemoreflex: evidence from genetic and pharmacological disruption and supplementation studies in mice J Appl Physiol, November 1, 2007; 103(5): 1772 - 1779. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Knudson, G. M. Dick, and J. D. Tune Adipokines and Coronary Vasomotor Dysfunction Experimental Biology and Medicine, June 1, 2007; 232(6): 727 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nakamura, W. Zhang, M. Yanagisawa, Y. Fukuda, and T. Kuwaki Vigilance state-dependent attenuation of hypercapnic chemoreflex and exaggerated sleep apnea in orexin knockout mice J Appl Physiol, January 1, 2007; 102(1): 241 - 248. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhang, T. Sakurai, Y. Fukuda, and T. Kuwaki Orexin neuron-mediated skeletal muscle vasodilation and shift of baroreflex during defense response in mice Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2006; 290(6): R1654 - R1663. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Knudson, U. D. Dincer, C. Zhang, A. N. Swafford Jr., R. Koshida, A. Picchi, M. Focardi, G. M. Dick, and J. D. Tune Leptin receptors are expressed in coronary arteries, and hyperleptinemia causes significant coronary endothelial dysfunction Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H48 - H56. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Meier and A. M. Gressner Endocrine Regulation of Energy Metabolism: Review of Pathobiochemical and Clinical Chemical Aspects of Leptin, Ghrelin, Adiponectin, and Resistin Clin. Chem., September 1, 2004; 50(9): 1511 - 1525. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ehmke and A. Just The orexins: linking circulatory control with behavior Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2003; 285(3): R519 - R521. [Full Text] [PDF] |
||||
![]() |
Y. Kayaba, A. Nakamura, Y. Kasuya, T. Ohuchi, M. Yanagisawa, I. Komuro, Y. Fukuda, and T. Kuwaki Attenuated defense response and low basal blood pressure in orexin knockout mice Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2003; 285(3): R581 - R593. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |